Efficacy of Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural or Peritoneal Effusions
Background and objective Once the malignant pleural or peritoneal effusion is developed it is difficult to control. This report presents a new method for controlling the malignant effusions. Methods Forty-eight patients, 29 males and 19 females with an average age of 61.2 years old, who were satisf...
Main Authors: | Xin ZHANG, Yi HU, Jinliang WANG, Sujie ZHANG, Haitao TAO, Sun JING, Baishou WU |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2013-03-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2013.03.07 |
Similar Items
-
A Comparative Study on Mean Levels of Amylase in Pleural and Peritoneal Effusions and Ratio of Pleural Peritoneal Fluid Amylase to Serum Amylase in Patients with Malignant Effusion and Reactive Effusion
by: Noushin Afshar Moghadam, et al.
Published: (2012-03-01) -
Accuracy of closed pleural biopsy in the diagnosis of malignant pleural effusion
by: Renata Báez-Saldaña, et al. -
The value of the assessment of serum and pleural Dikkopf-1 concentrations in the differentiation between malignant and non-malignant pleural effusions
by: Nourane Y. Azab, et al.
Published: (2016-01-01) -
Evaluation of pleural fluid YKL-40 as a marker of malignant pleural effusion
by: Adel Attia, et al.
Published: (2015-04-01) -
Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions
by: Maoshui Wang, et al.
Published: (2014-01-01)